PDF Solutions Q2FY26 Results: Revenue up 19% YoY to $61.5 million
- Revenue grew 19% YoY to $61.5 million in Q2FY26
- Total backlog increased 10% QoQ to $271 million
- EPS rose 42% YoY to $0.27 on non-GAAP basis
- Cash and equivalents surged to $114.9 million post-equity offering
- Full-year revenue growth guidance of 20% reaffirmed

*this image is generated using AI for illustrative purposes only.
PDF Solutions Inc reported second-quarter fiscal year 2026 revenues of $61.5 million, reflecting a 19% year-over-year increase. The semiconductor data analytics firm also saw its total backlog grow to $271 million, up 10% from the previous quarter.
The company reconfirmed its full-year guidance of 20% year-over-year revenue growth for 2026. Strong bookings momentum was driven by eight-figure contracts for SecureWise and DirectScan systems, alongside several seven-figure contracts for Exensio products. Demand in AI ecosystems continues to support this growth trajectory.
Financial Performance Overview
Revenue growth was supported by contributions from multiple product lines. Platform revenue reached $49.1 million, up 14% year-over-year. Volume-based revenue increased significantly by 45% compared to Q2 of last year, driven by strong gainshare and Cimetrix runtime licenses.
| Metric | Q2FY26 | Change vs Prior Year | Notes |
|---|---|---|---|
| Total Revenue | $61.5 million | +19% | Driven by multiple products |
| Platform Revenue | $49.1 million | +14% | Up 24% YTD |
| Gross Margin | 73% | Lower than Q1 | Due to fewer perpetual licenses |
| Operating Margin | 22% | +300 bps | Disciplined spend |
| EPS | $0.27 | +42% | Non-GAAP basis |
Gross margin for the quarter stood at 73%, lower than Q1 levels primarily due to a higher proportion of perpetual software licenses in the prior quarter. Management expects margins to revert to higher levels in the next quarter, with line-of-sight to the long-term target of 77%. Operating expenses rose only 5% year-over-year, contributing to an operating margin expansion of approximately 300 basis points.
Balance Sheet and Cash Flow
The company ended the quarter with cash and cash equivalents of $114.9 million, a substantial increase from $31.2 million in the prior quarter. This liquidity boost was aided by a follow-on equity offering that added $81.8 million to the balance sheet through the sale of approximately 1.9 million primary shares. Outstanding debt stands at $67.5 million.
Operating cash flow generated during the quarter was $16.4 million. Capital expenditure utilized $14.1 million, primarily for eProbe tools to meet customer demand. Management expects incremental capex increases in the next two quarters but anticipates ending the year with higher cash balances while reducing debt via scheduled payments.
What the Numbers Show
A notable divergence exists between the sequential decline in gross margin and the significant expansion in operating margin. While gross margin dipped to 73% due to mix shifts away from high-margin perpetual licenses, operating margin expanded by 300 basis points to 22%. This indicates that disciplined management of SG&A resources effectively offset the top-line margin pressure, allowing earnings per share to grow 42% year-over-year despite the gross margin contraction.
Strategic Developments
Key operational highlights include:
- Placement of three new eProbe inspection machines, with two going to new customers.
- Record eight-figure contract for SecureWise, expanding services to back-end test and assembly facilities.
- Cimetrix bookings reached record highs, reflecting robust activity across the equipment industry.
- Expansion of DirectScan systems into more mature process nodes and memory markets.
Management emphasized that the investment in semiconductors remains driven by the buildout of AI data centers. The company views itself as well-positioned to leverage AI agents for engineering and production execution within the semiconductor supply chain.
How will the anticipated increase in capital expenditure for eProbe tools in the next two quarters impact PDF Solutions' free cash flow generation and debt reduction timeline?
To what extent can the recent $81.8 million equity offering be deployed toward strategic acquisitions or R&D to sustain the 20% annual revenue growth guidance?
Given the divergence between gross margin contraction and operating margin expansion, what specific SG&A efficiencies are expected to persist as the company scales?


























